LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

Search

Fulgent Genetics Inc

Deschisă

SectorSănătate

21.46 1.66

Rezumat

Modificarea prețului

24h

Curent

Minim

20.65

Maxim

21.41

Indicatori cheie

By Trading Economics

Venit

-5.7M

-12M

Vânzări

-2.8M

73M

EPS

0.04

Marjă de profit

-16.197

Angajați

1,313

EBITDA

-2M

-12M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+15.27% upside

Dividende

By Dow Jones

Următoarele câștiguri

1 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

57M

629M

Deschiderea anterioară

19.8

Închiderea anterioară

21.46

Sentimentul știrilor

By Acuity

78%

22%

357 / 380 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Fulgent Genetics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 iun. 2025, 20:45 UTC

Câștiguri

Broadcom 2Q Sales Climb on Booming AI Demand

5 iun. 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 iun. 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 iun. 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 iun. 2025, 21:32 UTC

Câștiguri

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 iun. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5 iun. 2025, 20:45 UTC

Câștiguri

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 iun. 2025, 20:24 UTC

Câștiguri

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Rev $15B >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Net $4.97B >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Adj EPS $1.58 >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q EPS $1.03 >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom Sees 3Q Rev $15.8B >AVGO

5 iun. 2025, 20:11 UTC

Achiziții, Fuziuni, Preluări

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 iun. 2025, 20:11 UTC

Achiziții, Fuziuni, Preluări

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 iun. 2025, 20:11 UTC

Achiziții, Fuziuni, Preluări

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 iun. 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5 iun. 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 iun. 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5 iun. 2025, 18:26 UTC

Câștiguri

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 iun. 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 iun. 2025, 16:30 UTC

Achiziții, Fuziuni, Preluări

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 iun. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5 iun. 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 iun. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5 iun. 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5 iun. 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 iun. 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 iun. 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

Fulgent Genetics Inc Așteptări

Obiectiv de preț

By TipRanks

15.27% sus

Prognoză pe 12 luni

Medie 24 USD  15.27%

Maxim 25 USD

Minim 23 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruFulgent Genetics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

1

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

17.32 / 19.04Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Neutral Evidence

Sentiment

By Acuity

357 / 380 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.